LGC Group

Name

LGC Group

Legal name

LGC Limited

Website

https://lgcgroup.com

Company type

Private

Founded year

1842

Operating status

Operating

Headcount range

1,001–5,000 employees

Ownership category

akta.pro rank

Product category

Life Sciences Measurement and Testing

NAICS

Analytical Laboratory Instrument Manufacturing (334516), Research and Development in Biotechnology (except Nanobiotechnology) (541714), Scientific Research and Development Services (5417), In-Vitro Diagnostic Substance Manufacturing (325413), Testing Laboratories and Services (54138)

SIC

Laboratory Analytical Instruments (3826), Services-Testing Laboratories (8734), Services-Commercial Physical & Biological Research (8731), In Vitro & In Vivo Diagnostic Substances (2835), Medicinal Chemicals & Botanical Products (2833)

akta.pro primary industry

Impurity / Reference Standard Synthesis & Characterization (HLAGAHAG)

akta.pro secondary industries

Analytical Development & QC Testing (Release/Stability/Potency) (HLAGAGAF), Release Testing & Batch Certification (QC) (HLAGADAC), Analytical Instruments & Chromatography Systems (HLAGAIAA), Manufacturing Quality Assurance & GMP Compliance (batch release, deviation/CAPA, tech transfer QA) (HLAGAKAJ), Food, Feed & Nutraceutical Analytical Testing (HLAGADAN)

Keywords

• Reference materials standards
• Clinical diagnostics solutions
• Proficiency testing schemes
• Nucleic acid extraction
• Genomics genotyping services

Headquarters

HQ city

Teddington

HQ country

United Kingdom

HQ region

Europe

Offices4 records

Markets served

GTM type

B2B

Offering type

Services

Cost components

Personnel, Technology or R&D, Supply Chain, Operations, Infrastructure, Marketing or Sales

Revenue model

1. Reference Materials & Standards: Sale of certified reference materials, quality control standards, and proficiency testing solutions to laboratories and manufacturers for method validation and quality assurance.
2. Research Chemicals & Diagnostics: Research chemicals, clinical diagnostic products, and genomics tools sold to pharmaceutical, diagnostic, and research customers.
3. Nucleic Acid Services: Custom nucleic acid synthesis and purification services for diagnostics and therapeutics applications.
4. Proficiency Testing: Interlaboratory comparison programs and testing schemes for laboratory accreditation and quality assessment.

Pricing tiers

Go-to-market motion4 records

Distribution channels3 records

Marketing channels5 records

Core offering

LGC Group manufactures and supplies certified reference materials, analytical standards, research chemicals, and proficiency testing programs used by analytical and diagnostic laboratories worldwide. Through subsidiaries such as Biosearch Technologies, SeraCare, Lucigen, Rapid Genomics, and Axolabs, the company also provides nucleic acid extraction reagents, oligonucleotide synthesis, genotyping kits, clinical diagnostic reference materials, infectious disease reagents, and custom nucleic acid services to pharmaceutical, food safety, agrigenomic, and clinical diagnostics customers across 170+ countries.

Product overview

LGC Group offers a multi-brand portfolio of life sciences tools, analytical solutions, and diagnostic services organized into three main business segments: Diagnostics and Genomics (including SeraCare, Biosearch Technologies, Lucigen, and Rapid Genomics for clinical diagnostics, oligo synthesis, and genotyping); Assurance (encompassing LGC Standards with reference materials, research chemicals, proficiency testing via AXIO, Dr. Ehrenstorfer, Mikromol, and TRC brands, plus supply chain assurance with BRCGS and Informed Sport/Informed Choice certifications); and Nucleic Acid Therapeutics (Axolabs for oligonucleotide and mRNA development). The company operates National Laboratories including the National Measurement Laboratory and Government Chemist functions. Products serve pharmaceutical, clinical laboratory, food safety, agrigenomics, and environmental testing customers across 170+ countries through both direct sales and online stores.

Differentiator

Problem solved

Functional benefit

Brands

• LGC Standards: Global leader in research chemicals, analytical standards, and proficiency testing including AXIO Proficiency Testing, Dr. Ehrenstorfer, Mikromol, and Toronto Research Chemicals (TRC)
• Biosearch Technologies
• SeraCare
• Lucigen
• Axolabs
• The Native Antigen Company (TNAC)
• DiaMex / Optitrol
• VHG Labs
• Informed Sport
• Informed Choice
• National Measurement Laboratory
• Government Chemist

Products and services

• LGC Standards (Reference Materials, Research Chemicals & Proficiency Testing) Global reference materials, analytical reference standards, research chemicals, and proficiency testing programs for pharmaceutical, food safety, environmental, forensic, and clinical testing laboratories. Operates trusted brands including AXIO Proficiency Testing, Dr. Ehrenstorfer, Mikromol, and Toronto Research Chemicals (TRC), with a comprehensive PFAS portfolio.
• SeraCare Clinical Diagnostics Clinical diagnostics quality solutions including NGS controls, reference standards, assay tools, and immunoassay reagents and kits serving IVD developers, biopharma, CROs, and academic institutions.
• Biosearch Technologies (Oligo Synthesis) End-to-end diagnostic solutions including oligonucleotides, reagents, KASP assays, BHQplus probes, and instruments (oKtopure, SNPline, Nexar, IntelliQube) with GMP, GLP, and ISO compliance for infectious diseases, oncology, and prenatal testing.
• Lucigen Reagent Components Reagents, instruments, and consumables for nucleic acid chemistry, PCR, sample preparation, sequencing, enzymes, and competent cells used in molecular biology research and diagnostic applications.
• Rapid Genomics Genotyping Solutions Genotyping kits and services using Next-Generation Sequencing technology for the agrigenomics market. Offers targeted genotyping by sequencing (GBS), Flex-Seq, Capture-Seq, and nGBS/ddRAD services for crop and livestock genetics.
• Supply Chain Assurance Supply chain assurance services for food and sports nutrition industries, including globally recognized certifications, testing, and digital assurance tools under BRCGS and INFORMED brands. Includes Informed Sport and Informed Choice certification programs.
• National Laboratories & Science UK National Measurement Laboratory and Government Chemist functions providing measurement science, regulatory analysis, and reference measurement procedures for food, medicines, and environmental testing in support of UK government initiatives.
• Axolabs (Nucleic Acid Therapeutics) Contract development, analysis, and production of oligonucleotide- and mRNA-based therapeutics. Provides comprehensive services from early discovery through commercialization for antisense oligonucleotides and nucleic acid drugs.
• BRCGS Certification Global standards and certification programs for food safety, packaging materials, storage and distribution, consumer products, agents and brokers, retail, gluten-free, plant-based, and ethical trading.
• Informed Sport / Informed Choice Global banned substance testing and certification programs for sports supplements and nutrition products, using ISO/IEC 17025 accredited methods to test for over 285 substances banned in sport.
• Amp-Seq One One-step targeted genotyping by sequencing workflow offering the fastest amplicon sequencing protocol on the market, with a 120-minute total turnaround time that halves hands-on time and doubles throughput for agricultural genotyping and breeding programs.
• SARS-CoV-2 Ultra-High-Throughput End-Point PCR Test FDA Emergency Use Authorized COVID-19 PCR diagnostic test using the Nexar workflow that delivers 5,000 test results per hour for high-volume centralized testing with self-collected nasal swab samples.
• Seraseq DPYD DNA Mutation Mix Reference material for developing, validating, and evaluating NGS and molecular assays that detect critical mutations in the DPYD gene, supporting pharmacogenomics and personalized medicine applications.
• Seraseq Inherited Cancer DNA Mix v2 Comprehensive reference material for validation and quality control of cancer-predisposition assays, containing 61 clinically relevant variants across 56 cancer-associated genes in a single-vial multiplexed format. Supports CAP and CLIA compliance.
• sbeadex Lightning Proprietary nucleic acid extraction kit/process that delivers high-purity DNA in approximately 5 minutes using room temperature stable reagents, intended for agricultural genomics and other high-throughput applications.
• The Native Antigen Company (TNAC) Infectious disease reagents, antibodies, and assays including over 900 viral and infectious disease products, with recognized strengths in Coronavirus, Dengue, CMV, Zika, Chikungunya, and C. difficile. Based in Oxford, UK.
• Kova International Quality Control Products In vitro urinalysis and toxicology quality control products for clinical laboratories, including Biochemical Diagnostics offerings, used for routine and specialized clinical testing workflows.
• Lipomed Reference Standards Analytical reference standards for pharmaceutical, clinical, forensic, and environmental testing applications, complementing LGC's broader reference materials portfolio.
• Virusys Corporation Reagents Monoclonal antibodies and viral antigens used in infectious disease research and diagnostic development, complementing LGC Clinical Diagnostics' antigen product portfolio.
• DiaMex Optitrol Quality Controls Third-party serology and molecular quality controls used in clinical laboratories and blood banks worldwide, including the Optitrol product range, complementing LGC's serology and molecular quality control portfolio.
• ChromaDex Reference Standards Analytical reference standards business serving pharmaceutical, laboratory, and food production customers, expanding LGC's North American reference materials portfolio.

Quantifiable outcome

• Serving pharmaceutical, laboratory, and diagnostic customers in 170+ countries worldwide

Named customers3 records

Segments7 records

Ideal customer profiles6 records

Technology focussed Yes

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Feature4 records

Partnerships

Eight partnerships are on record, tiered core.

• GenolutioncoreTechnology or Integration · 1 September 2025Partnership for nucleic acid purification technologies, combining expertise to deliver advanced solutions for molecular diagnostics and research applications.
• Dynamic DevicescoreStrategic or Co-development Partner · 1 April 2025Strategic partnership for development of diagnostic and analytical solutions. Collaboration aimed at advancing laboratory testing technologies and automation.
• AccuGenomicscoreStrategic or Co-development Partner · 1 September 2024Strategic partnership to enhance cancer testing accuracy through improved nucleic acid analysis technologies. Collaboration focuses on integrating technologies to advance precision diagnostics in oncology.
• IlluminacoreTechnology or Integration · 1 September 2024Strategic partnership for agricultural genomics applications combining LGC's genotyping technologies with Illumina's sequencing platforms for enhanced agricultural research and breeding programs.
• Stanford MedicinecoreStrategic or Co-development PartnerExtended collaboration for Non-Invasive Prenatal Testing (NIPT) development, advancing clinical diagnostics capabilities in prenatal screening.
• Queen's University BelfastcoreStrategic or Co-development PartnerCentre for Excellence in Agriculture and Food Integrity partnership for research collaboration in food safety, quality assurance, and agricultural standards.
• University of LeedscoreStrategic or Co-development PartnerCell metrology laboratory collaboration for advanced measurement research and development of analytical methodologies.
• University of StrathclydecoreStrategic or Co-development PartnerCentre for Advanced Measurement Research partnership for development of reference standards and measurement technologies.

Scale indicators6 records

Recent moves11 records

Expansion highlights6 records

Broad incumbents

• Agilent Technologies: Agilent provides analytical instruments (mass spectrometry, chromatography) and consumables that overlap with LGC's analytical instrumentation and reference materials for pharmaceutical, food, and environmental testing customers.
• Waters Corporation: Waters provides chromatography and mass spectrometry systems used alongside LGC's analytical standards and reference materials, and increasingly competes in connected lab informatics for regulated testing environments.
• Sartorius AG: Sartorius supplies bioprocessing and lab products to pharmaceutical and life science customers, overlapping with LGC's biopharma QC materials, reference standards, and laboratory instrumentation portfolio.
• Thermo Fisher Scientific: Thermo Fisher is a broad incumbent across analytical instruments, life science reagents, diagnostics, and reference standards (through its Specialty Diagnostics and Analytical Instruments segments), overlapping with multiple LGC product lines.
• Merck KGaA (Life Science / Sigma-Aldrich): Merck KGaA's Life Science segment (including Sigma-Aldrich) is a broad incumbent in analytical reagents, reference materials, and lab consumables; it competes with LGC Standards across research chemicals, analytical standards, and biopharma QC.
• Charles River Laboratories: Charles River provides life science research services and reference materials (CRLs, standards, diagnostic tools) to biopharma, competing with LGC's research chemical and biopharma QC offerings.
• PerkinElmer (Revvity): Revvity (formerly PerkinElmer) competes with LGC across life sciences reagents, clinical diagnostics, and analytical standards, particularly in newborn screening and genomics workflows served by Biosearch.

Direct peers

• QIAGEN: QIAGEN is a direct peer in nucleic acid extraction (compare to sbeadex), sample preparation technologies, and molecular diagnostics consumables used in infectious disease, oncology, and NIPT workflows served by LGC's Biosearch Technologies.
• Eurofins Scientific: Eurofins is a direct peer in commercial laboratory testing, proficiency testing schemes, and reference materials, serving pharmaceutical, food, and environmental clients globally much like LGC's Assurance segment.
• Bio-Rad Laboratories: Bio-Rad is the closest direct comparable to LGC, offering clinical diagnostics quality controls, life science research reagents, and digital PCR/analytical instruments (e.g., Droplet Digital PCR) that overlap directly with LGC's SeraCare, Biosearch Technologies, and reference materials portfolio.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat5 records

Key risks6 records

Key highlights7 records

Customer concentration

• LinkedInlinkedin.com/company/lgc-group
• Xx.com/lgcgroup

Compliance6 records

Revenue estimate

Valuation estimate

Number of profiles

Profiles19 records

Subsidiaries14 records

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A21 records

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about LGC Group